{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T23:06:08Z","timestamp":1769727968368,"version":"3.49.0"},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T00:00:00Z","timestamp":1305158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[2011,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background and Aim:\u2002<\/jats:bold> To investigate the therapeutic effect of ligustrazine on hepatic veno\u2010occlusive disease (HVOD) induced by Gynura segetum and the possible mechanism of it.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Female Kunming mice (115) were randomly divided into four groups, gavaged with 30\u2003g\/kg per day Gynura segetum (group A), 30\u2003g\/kg per day Gynura segetum\u2003+\u2003100\u2003mg\/kg per day ligustrazine (group B), 30\u2003g\/kg per day Gynura segetum\u2003+\u2003200\u2003mg\/kg per day ligustrazine (group C) or 30\u2003mL\/kg per day phosphate\u2010buffered saline (PBS) (group D). Thirty days later, all of the mice were killed. Blood samples and livers were harvested. Histological changes were evaluated by light microscopy. Liver function was measured, and the expression of tissue factor (TF), early growth response factor\u20101 (Egr\u20101) and nuclear factor\u2010KBp65 (NF\u2010KBp65) were determined by reverse transcription\u2010polymerase chain reaction and Western blot.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> A total of 24 mice in group A developed HVOD. Compared with the controls, they had increased liver ratio, serum total bilirubin (TBIL), direct bilirubin (DBIL), transaminase and decreased albumin (ALB) (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). Administration of ligustrazine improved the clinical signs and biochemistry parameters in a dose\u2010dependent manner. Compared with group A, the expression of TF, Egr\u20101 and NF\u2010KB p65 decreased in groups B and C (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05).<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Ligustrazine has a therapeutic effect on HVOD, improving clinical manifestations and liver function. The possible mechanism may be that ligustrazine could reduce the expression of TF by downregulating the expression of transcription factors: Egr\u20101 and NF\u2010KB p65.<\/jats:p>","DOI":"10.1111\/j.1440-1746.2011.06661.x","type":"journal-article","created":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T06:41:22Z","timestamp":1295505682000},"page":"1016-1021","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effect of ligustrazine on mice model of hepatic veno\u2010occlusive disease induced by Gynura segetum"],"prefix":"10.1111","volume":"26","author":[{"given":"Zhe","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u2010Rong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong\u2010Yi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,5,12]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840040121"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01680.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.4065\/78.5.589"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i29.3918"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-32569"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2005.10.007"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7254.2007.00514.x"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290615"},{"key":"e_1_2_5_10_2","first-page":"395","article-title":"Reliable experimental model of hepatic veno\u2010occlusive disease caused by monocrataline","volume":"7","author":"Chen MY","year":"2008","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"e_1_2_5_11_2","first-page":"311","article-title":"Analysis of alkaloids in Sedum aizoon and establishment of hepatic veno\u2010occlusive model in mice","volume":"14","author":"Gao XS","year":"2006","journal-title":"Chin. J. Integr. Tradit. West. Med. Dig."},{"key":"e_1_2_5_12_2","first-page":"191","article-title":"Studies on the alkaloids of Gynura segetum (Lour.) Merr","volume":"25","author":"Yuan SQ","year":"1990","journal-title":"Yaoxue Xuebao"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/19960404NT3"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1021\/tx000149o"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701445"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0b013e3282f2b5d9"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702209"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705899"},{"key":"e_1_2_5_19_2","first-page":"579","article-title":"Induction of plasminogen activator inhibitor 1 gene expression in murine liver by lipopolysaccharide. Cellular localization and role of endogenous tumor necrosis factor\u2010alpha","volume":"150","author":"Fearns C","year":"1997","journal-title":"Am. J. Pathol."},{"key":"e_1_2_5_20_2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0037-1615693","article-title":"Effect of intradermal tumor necrosis factor\u2010\u03b1\u2010induced inflammation on coagulation factors in dermal vessel endothelium","volume":"85","author":"Speiser W","year":"2001","journal-title":"Thromb. Haemost."},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0268-960X(03)00002-X"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2004.12.010"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91646-4"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1517\/14712590903008507"},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/blood.V108.11.43.43","article-title":"Defibrotide (DF) for the treatment of severe veno\u2010occlusive disease (sVOD) and multi\u2010organ failure (MOF) post SCT: final results of a multi\u2010center, randomized, dose\u2010finding trial","volume":"108","author":"Richardson P","year":"2006","journal-title":"Blood"},{"key":"e_1_2_5_26_2","first-page":"2330","article-title":"Influence of tetramethylpyrazine on the tissue factor expression induced by TNF\u03b1 in endothelial cells","volume":"17","author":"Xiong SL","year":"2007","journal-title":"China J. Mod. Med."},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0346"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.8.3849"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0346"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.2011.06661.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.2011.06661.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T02:24:07Z","timestamp":1697336647000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.2011.06661.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,12]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["10.1111\/j.1440-1746.2011.06661.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.2011.06661.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,12]]},"assertion":[{"value":"2011-05-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}